BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11138909)

  • 21. Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women.
    Teixeira NC; Araújo AC; Correa CM; Lodi CT; Lima MI; Carvalho Nde O; Castillo DM; Melo VH
    Braz J Infect Dis; 2012; 16(2):164-9. PubMed ID: 22552459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
    Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
    Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Palefsky JM
    Curr Opin Oncol; 2003 Sep; 15(5):382-8. PubMed ID: 12960521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears.
    Rozendaal L; Walboomers JM; van der Linden JC; Voorhorst FJ; Kenemans P; Helmerhorst TJ; van Ballegooijen M; Meijer CJ
    Int J Cancer; 1996 Dec; 68(6):766-9. PubMed ID: 8980181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer and women with HIV.
    Denenberg R
    GMHC Treat Issues; 1997; 11(7-8):10-8. PubMed ID: 11364643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical-vaginal disease in HIV immunosuppressed patients: management and present screening programme.
    Di Stefano L; Coppola G; Moro S; Colageo E; Cellini A; Coletti G
    Eur J Gynaecol Oncol; 2006; 27(3):267-70. PubMed ID: 16800255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi.
    Motti PG; Dallabetta GA; Daniel RW; Canner JK; Chiphangwi JD; Liomba GN; Yang L; Shah KV
    J Infect Dis; 1996 Mar; 173(3):714-7. PubMed ID: 8627037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research.
    Menon S; Rossi R; Zdraveska N; Kariisa M; Acharya SD; Vanden Broeck D; Callens S
    BMJ Open; 2017 Aug; 7(8):e015123. PubMed ID: 28780541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study.
    Wensveen C; Kagie M; Veldhuizen R; De Groot C; Denny L; Zwinderman K; Trimbos B
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):883-9. PubMed ID: 12911453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Int J STD AIDS; 2008 Jan; 19(1):37-41. PubMed ID: 18275645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of human papillomavirus and cervical intraepithelial neoplasia in a young Australian STD population.
    McKinnon KJ; Ford RM; Hunter JC
    Int J STD AIDS; 1991; 2(4):276-9. PubMed ID: 1655057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of cervical cancer in women with HIV.
    Heard I
    Curr Opin HIV AIDS; 2009 Jan; 4(1):68-73. PubMed ID: 19339941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.
    Minkoff H; Ahdieh L; Massad LS; Anastos K; Watts DH; Melnick S; Muderspach L; Burk R; Palefsky J
    AIDS; 2001 Nov; 15(16):2157-64. PubMed ID: 11684935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1).
    Heard I; Tassie JM; Schmitz V; Mandelbrot L; Kazatchkine MD; Orth G
    Obstet Gynecol; 2000 Sep; 96(3):403-9. PubMed ID: 10960634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
    BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus testing in primary cervical screening.
    Cuzick J; Szarewski A; Terry G; Ho L; Hanby A; Maddox P; Anderson M; Kocjan G; Steele ST; Guillebaud J
    Lancet; 1995 Jun; 345(8964):1533-6. PubMed ID: 7791438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.